| 摘要: |
| [目的] 探讨穿心莲内酯调节声波刺猬(SHH)/GLI家族锌指蛋白(GLI1)信号通路对直肠癌细胞活性和化疗耐药性的影响。[方法] 采用3.75~120 μmol/L穿心莲内酯处理人结直肠癌耐药细胞株SW20/5-FU,检测细胞增殖活力,筛选穿心莲内酯实验浓度。将SW20/5-FU细胞随机分为对照组(Control组)、穿心莲内酯低、中、高浓度组(AND-L组、AND-M组、AND-H组)、高浓度穿心莲内酯+SHH信号通路抑制剂组(Cyclopamine组);检测SW20/5-FU细胞的增殖、迁移、侵袭能力;检测上皮间质转化(EMT)和通路蛋白表达。[结果] 通过检测细胞增殖活力,选用15.0、30.0、60.0 μmol/L的穿心莲内酯作处理浓度。与Control组比较,AND-L、AND-M、AND-H组细胞克隆形成数、划痕愈合率、侵袭数量降低,细胞周期蛋白D1(CyclinD1)、基质金属蛋白酶-2(MMP-2)、基质金属蛋白酶-9(MMP-9)、神经钙黏蛋白(N-Cadherin)、波形蛋白(Vimentin)表达水平下降,上皮性黏附蛋白(E-Cadherin)、SHH、GLI1蛋白表达水平升高(P<0.05);与AND-H组比较,Cyclopamine组克隆形成数、划痕愈合率、侵袭数量上升,CyclinD1、MMP-2、MMP-9、N-Cadherin、Vimentin表达水平升高,E-Cadherin、SHH、GLI1蛋白表达水平降低(P<0.05)。[结论] 穿心莲内酯激活SHH/GLI1信号通路抑制直肠癌细胞增殖、迁移、侵袭与EMT能力,从而改善化疗耐药性。 |
| 关键词: 直肠癌 穿心莲内酯 SHH/GLI1信号通路 化疗耐药性 |
| DOI:10.11656/j.issn.1672-1519.2026.03.11 |
| 分类号:R285.5 |
| 基金项目:青岛市医药卫生科研指导项目(2023-WJZD205)。 |
|
| Effect of andrographolide on the activity and chemotherapy resistance of rectal cancer cells by regulating the SHH/GLI1 signaling pathway |
|
LIU Kun, LIU Lihua, HOU Weijing, LU Lin, ZHANG Meihua
|
|
Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao 266042, China
|
| Abstract: |
| [Objective] To investigate the effect of andrographolide on the activity and chemotherapy resistance of rectal cancer cells by regulating the sonic hedgehog(SHH)/GLI family zinc finger protein 1(GLI1) signaling pathway. [Methods] Human colorectal cancer drug-resistant cell line SW20/5-FU was treated with 3.75 to 120 μmol/L of andrographolide,and cell proliferation activity was detected. The experimental concentration of andrographolide was screened. SW20/5-FU cells were randomly divided into Control group,low,medium,and high concentration andrographolide groups(AND-L group,AND-M group,AND-H group),and high concentration andrographolide + SHH signaling pathway inhibitor group(Cyclopamine group). The proliferation,migration,and invasion abilities of SW20/5-FU cells were detected. Epithelial mesenchymal transition(EMT) and pathway protein expression were detected. [Results] By detecting cell proliferation activity,the concentrations of andrographolide at 15.0,30.0,and 60.0 μmol/L were selected as the treatment concentrations. Compared with the Control group,the number of cell clones formed,scratch healing rate,and number of invasions decreased in AND-L,AND-M,and AND-H groups,while the expression levels of G1/S-specific cyclin D1(Cyclin D1),matrix metalloproteinase-2(MMP-2),matrix metalloproteinase-9(MMP-9),neural cadherin(N-Cadherin),and Vimentin decreased,the expression levels of epithelial cadherin(E-Cadherin),SHH,and GLI1 proteins increased(P<0.05). Compared with the AND-H group,the number of cell clones formed,scratch healing rate,and number of invasions increased in Cyclopamine group,while the expression levels of CyclinD1,MMP-2,MMP-9,N-Cadherin,and Vimentin increased,the expression levels of E-Cadherin,SHH,and GLI1 proteins decreased(P<0.05). [Conclusion] Andrographolide activates the SHH/GLI1 signaling pathway to inhibit the proliferation,migration,invasion,and EMT ability of rectal cancer cells,thereby improving chemotherapy resistance. |
| Key words: rectal cancer andrographolide SHH/GLI1 signaling pathway chemotherapy resistance |